Human rights and drug control : access to controlled essential medicines in resource-constrained countries / Marie Elske Gispen.
Material type:
TextSeries: School of Human Rights Research series ; v. 80.Publication details: Cambridge, United Kingdom ; Portland, OR : Intersentia, [2017]Description: xxiii, 351 pages : illustrations ; 24 cmISBN: - 9781780684543
- 1780684541
- JC571 .G52 2017
| Cover image | Item type | Current library | Home library | Collection | Shelving location | Call number | Materials specified | Vol info | URL | Copy number | Status | Notes | Date due | Barcode | Item holds | Item hold queue priority | Course reserves | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Books
|
African Court on Human and Peoples' Rights Library | JC571 .G52 2017 (Browse shelf(Opens below)) | Available | Donation by Raoul Wallenberg Institute, November 2021 | 10197257 |
Includes bibliographical references (pages 331-345) and index.
Access to Controlled Essential Medicines: Context, Background, Framing, and Focus -- Access to Controlled Essential Medicines and Aspects of Drug Control in Human Rights Law -- In Search of a Normative Justification -- Bridging Theory and Practice: Introduction to the Country Studies -- Country Study I : Uganda -- Country Study II : Latvia.
"Globally, millions of people suffer health and socio-economic related problems due to the unavailability of controlled essential medicines, such as morphine for pain treatment, which leaves them in disabling and sometimes degrading situations. Controlled essential medicines are medicines included in the World Health Organization's List of Essential Medicines, and whose active substance is listed under the international drug-control treaties. Their availability and accessibility therefore fall within the remit of both human rights and international drug-control law. Even though the unavailability of controlled essential medicines is generally caused by a multifaceted and complex interplay of factors, the current international drug-control framework paradoxically hinders rather than fosters the access to medicines"--Back cover.
There are no comments on this title.
